In the DFCI cohort, 77.1% of BRAF/PIK3CA double mutant colorectal cancers and 65.2% of BRAF mutant cancers with wild type PIK3CA have a TMB above 200 (Table 4). This evidence concerns the gene BRAF and cancer.